University of Cincinnati Digestive Diseases Training Programs:

Fellows Schedule:

Schedule consists of twelve approximately four week blocks. Each year fellows have two blocks dedicated to research. Four weeks of vacation is scheduled into the rotation while on research, nutrition or manometry.

Research:

Fellows have 6 months of protected research over 3 years. Research opportunities range from bench and translational research to clinical and quality improvement. Fellows can perform research through the University of Cincinnati, the VA Health system or with our colleagues at Cincinnati Childrens one of the top pediatric gastroenterology departments in the United States and a leader in research. Below is a list of current and past projects fellows have been a part of.

• Validation of the CAR-OLT score in our cohort and explore if additional predictors of cardiac outcomes can be identified and the score can be modified

• Evaluating the efficacy of ERCP stenting and identify risk factors for PEP

• Review of post LT database on patients who has h/o IBD prior to LT. The goal is to see if LT immune suppression is good enough to provide post LT IBD control

• Review of EGD data to identify predictors that can differentiate between benign and malignant ulcers. Project also includes evaluation of cost effectiveness of EGDs in this patient population

• Prospective clinical trial to assess frailty index and quality of life in patients with advanced liver cirrhosis being placed on liver wait-list. Assessments will be repeated after patients undergo liver transplantation to assess the impact of LT on these measures

• Improving patient safety by Improving pre-anesthetic documentation prior to planned endoscopic procedures

• Improving vaccination rates for viral hepatitis in liver clinics

• Frailty and sarcopenia in liver transplant candidates

• cardiovascular outcomes in liver transplant recipients

• Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults

• Gastroenterological Manifestations in a Patient with Common Variable Immunodeficiency Hepatitis C and the PCP: Initiation of hepatitis C treatment in resident primary care clinics

• Bezlotoxumab for recurrent C difficile in a large academic center

• Pulmonary manifestations of inflammatory bowel disease

• QUALITY OF CARE AND READMISSION RATES FOR CIRRHOTIC PATIENTS. Retrospective analysis with creation of order set and BPA to improve quality of care and outcomes

• Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial. Liver transplantation

• Effect of Mirtazapine on Nausea in Children with Functional Nausea and Functional Dyspepsia Postprandial Distress Syndrome.

• Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults

• Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults

• Review of Artificial Intelligence in Pancreatic and Biliary disease

• Retrospective Cohort Study of the Effectiveness of Pre-Endoscopic Erythromycin for UGIB at UCMC

 Training Sites:

Fellows spend their time between the University of Cincinnati Medical Center and the Cincinnati VA (Top 10 VA in the Nation). Best part is that they are located only a short walk from each other!